Cargando…
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
Cardiovascular disease (CVD) is common in patients with diabetes mellitus (DM) and related clinical outcomes are worse compared with non-diabetics. The optimal treatment in diabetic patients with coronary heart disease (CHD) is currently not established. We searched MEDLINE (1975-2010) using the key...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265001/ https://www.ncbi.nlm.nih.gov/pubmed/22328892 http://dx.doi.org/10.5114/aoms.2011.26621 |
_version_ | 1782222029370425344 |
---|---|
author | Athyros, Vasilios G. Gossios, Thomas D. Tziomalos, Konstantinos Florentin, Matilda Karagiannis, Asterios Mikhailidis, Dimitri P. |
author_facet | Athyros, Vasilios G. Gossios, Thomas D. Tziomalos, Konstantinos Florentin, Matilda Karagiannis, Asterios Mikhailidis, Dimitri P. |
author_sort | Athyros, Vasilios G. |
collection | PubMed |
description | Cardiovascular disease (CVD) is common in patients with diabetes mellitus (DM) and related clinical outcomes are worse compared with non-diabetics. The optimal treatment in diabetic patients with coronary heart disease (CHD) is currently not established. We searched MEDLINE (1975-2010) using the key terms diabetes mellitus, coronary heart disease, revascularization, coronary artery bypass, angioplasty, coronary intervention and medical treatment. Most studies comparing different revascularization procedures in patients with CHD favoured coronary artery bypass graft (CABG) surgery in patients with DM. However, most of this evidence comes from subgroup analyses. Recent evidence suggests that advanced percutaneous coronary intervention (PCI) techniques along with best medical treatment may be non-inferior and more cost-effective compared with CABG. Treatment of vascular risk factors is a key option in terms of improving CVD outcomes in diabetic patients with CHD. The choice between medical therapy and revascularization warrants further assessment. |
format | Online Article Text |
id | pubmed-3265001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-32650012012-02-10 Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? Athyros, Vasilios G. Gossios, Thomas D. Tziomalos, Konstantinos Florentin, Matilda Karagiannis, Asterios Mikhailidis, Dimitri P. Arch Med Sci State of the Art Paper Cardiovascular disease (CVD) is common in patients with diabetes mellitus (DM) and related clinical outcomes are worse compared with non-diabetics. The optimal treatment in diabetic patients with coronary heart disease (CHD) is currently not established. We searched MEDLINE (1975-2010) using the key terms diabetes mellitus, coronary heart disease, revascularization, coronary artery bypass, angioplasty, coronary intervention and medical treatment. Most studies comparing different revascularization procedures in patients with CHD favoured coronary artery bypass graft (CABG) surgery in patients with DM. However, most of this evidence comes from subgroup analyses. Recent evidence suggests that advanced percutaneous coronary intervention (PCI) techniques along with best medical treatment may be non-inferior and more cost-effective compared with CABG. Treatment of vascular risk factors is a key option in terms of improving CVD outcomes in diabetic patients with CHD. The choice between medical therapy and revascularization warrants further assessment. Termedia Publishing House 2011-12-30 2011-12-31 /pmc/articles/PMC3265001/ /pubmed/22328892 http://dx.doi.org/10.5114/aoms.2011.26621 Text en Copyright © 2011 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | State of the Art Paper Athyros, Vasilios G. Gossios, Thomas D. Tziomalos, Konstantinos Florentin, Matilda Karagiannis, Asterios Mikhailidis, Dimitri P. Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
title | Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
title_full | Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
title_fullStr | Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
title_full_unstemmed | Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
title_short | Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
title_sort | is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
topic | State of the Art Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265001/ https://www.ncbi.nlm.nih.gov/pubmed/22328892 http://dx.doi.org/10.5114/aoms.2011.26621 |
work_keys_str_mv | AT athyrosvasiliosg isthereanadditionalbenefitfromcoronaryrevascularizationindiabeticpatientswithacutecoronarysyndromesorstableanginawhoarealreadyonoptimalmedicaltreatment AT gossiosthomasd isthereanadditionalbenefitfromcoronaryrevascularizationindiabeticpatientswithacutecoronarysyndromesorstableanginawhoarealreadyonoptimalmedicaltreatment AT tziomaloskonstantinos isthereanadditionalbenefitfromcoronaryrevascularizationindiabeticpatientswithacutecoronarysyndromesorstableanginawhoarealreadyonoptimalmedicaltreatment AT florentinmatilda isthereanadditionalbenefitfromcoronaryrevascularizationindiabeticpatientswithacutecoronarysyndromesorstableanginawhoarealreadyonoptimalmedicaltreatment AT karagiannisasterios isthereanadditionalbenefitfromcoronaryrevascularizationindiabeticpatientswithacutecoronarysyndromesorstableanginawhoarealreadyonoptimalmedicaltreatment AT mikhailidisdimitrip isthereanadditionalbenefitfromcoronaryrevascularizationindiabeticpatientswithacutecoronarysyndromesorstableanginawhoarealreadyonoptimalmedicaltreatment |